Researchers from MIT's Computer Science and Artificial Intelligence Laboratory (CSAIL) have developed a novel artificial ...

Additionally, Schrödinger presented its first preclinical data for SGR-4174, its SOS1 inhibitor that disrupts the interaction between SOS1 and KRAS, the most frequently mutated oncogene in human ...

Once upon a time, machines displaced factory workers. Then algorithms came for office clerks. Today, generative AI is ...

Neurological disorders, including Alzheimer’s, Parkinson’s, ALS, and multiple sclerosis, pose significant challenges due to their complex pathophysiology ...

Alto Neuroscience, Inc. ("Alto") a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced multiple ...

Artificial intelligence models, pretrained on vast datasets, significantly outperformed a standard baseline model in ...

This episode offers two looks at prediction markets. In the first half of the show, Kalshi CEO Tarek Mansour joins Motley ...

Researchers from Nanjing University and Carnegie Mellon University have introduced an AI approach that improves how machines learn from past data—a process known as offline reinforcement learning.

To provide the right treatment for multiple sclerosis (MS), it is important to know when the disease changes from ...

Chinese tech company Alibaba released Qwen 3, a family of AI models that the company claims outperforms some of the best.

To provide the right treatment for MS, it is important to know when the disease changes from relapsing-remitting to secondary progressive, a transition that is currently recognized on average three ...

Identifying predictors of treatment response to repetitive transcranial magnetic stimulation (rTMS) remain elusive in treatment-resistant depression (TRD). Leveraging electronic medical records (EMR), ...